Prolactin-induced mouse mammary carcinomas model estrogen resistant luminal breast cancer. - Wikidata - wikimedia - TriplyDB

Prolactin-induced mouse mammary carcinomas model estrogen resistant luminal breast cancer.

Prolactin-induced mouse mammary carcinomas model estrogen resistant luminal breast cancer.

http://www.wikidata.org/entity/Q35029548

about

Prolactin cooperates with loss of p53 to promote claudin-low mammary carcinomas Genetically engineered ERα-positive breast cancer mouse models.A systematic review of non-hormonal treatments of vasomotor symptoms in climacteric and cancer patients Tumor subtype-specific associations of hormone-related reproductive factors on breast cancer survival Negative cross talk between NFAT1 and Stat5 signaling in breast cancer.Signal transducer and activator of transcription 5 as a key signaling pathway in normal mammary gland developmental biology and breast cancer.Mouse models of estrogen receptor-positive breast cancer Prolactin promotes mammary pathogenesis independently from cyclin D1.Tyrosyl phosphorylated serine-threonine kinase PAK1 is a novel regulator of prolactin-dependent breast cancer cell motility and invasion.Autocrine prolactin: an emerging market for homegrown (prolactin) despite the imports.Modeling prolactin actions in breast cancer in vivo: insights from the NRL-PRL mouse.Stiff collagen matrices increase tumorigenic prolactin signaling in breast cancer cells.GHR/PRLR Heteromultimer Is Composed of GHR Homodimers and PRLR Homodimers A 20-year prospective study of plasma prolactin as a risk marker of breast cancer development.Prolactin activates ERα in the absence of ligand in female mammary development and carcinogenesis in vivo Elevated collagen-I augments tumor progressive signals, intravasation and metastasis of prolactin-induced estrogen receptor alpha positive mammary tumor cells.Prolactin-Stat5 signaling in breast cancer is potently disrupted by acidosis within the tumor microenvironment.Stat5 in breast cancer: potential oncogenic activity coincides with positive prognosis for the disease.Progesterone receptors (PR) mediate STAT actions: PR and prolactin receptor signaling crosstalk in breast cancer models.Truncating Prolactin Receptor Mutations Promote Tumor Growth in Murine Estrogen Receptor-Alpha Mammary Carcinomas.Pathobiology of the 129:Stat1 -/- mouse model of human age-related ER-positive breast cancer with an immune infiltrate-excluded phenotype Prolactin Alters the Mammary Epithelial Hierarchy, Increasing Progenitors and Facilitating Ovarian Steroid Action Breast cancer: the menacing face of Janus kinase.c-Kit is required for growth and survival of the cells of origin of Brca1-mutation-associated breast cancer.Determinants of prolactin in postmenopausal Chinese women in Singapore.The prolactin receptor: Diverse and emerging roles in pathophysiology.Aberrantly high expression of the CUB and zona pellucida-like domain-containing protein 1 (CUZD1) in mammary epithelium leads to breast tumorigenesis.

P2860

Q33555787-6E57F739-2AEC-4010-AE54-7D7B6651604C Q33578641-615241A0-297E-4ADF-9DAE-26F7F8AA7F47 Q35092002-850DD322-0930-42C8-939D-3B9A72D2018D Q35416463-FCB0E6D1-D9EE-4E85-B064-A19716706171 Q35595651-3ACB2AAF-87BE-42C5-9C9B-5A076A892329 Q35683515-19B8045B-52FA-40BA-82EF-A11B1FB94B77 Q35685892-572DC549-8288-4023-A2FB-4B688C0F2B96 Q36071812-1D8D0426-41C7-41D6-B7A6-004D18D40E73 Q36078608-B77BD74D-2DA7-4A42-83A4-CAB351E39C9E Q36331355-69AA75FA-F40A-412D-8205-2B88B487C027 Q36629985-9E664349-28F6-43CA-A72C-06D4F072CE3B Q36812402-A5149A1E-811F-4B80-A4D8-3FD522C9BB9E Q36859543-AFF3909A-1F09-4CD4-A7DC-6DFA3ED028F3 Q37082963-14BB057D-1E6E-4D88-9660-1C8A1FE739A3 Q37331101-164FC1F2-FF08-4573-A042-7DD8618DF387 Q37593533-510F0C9A-A388-467E-B05B-03E5E88340E1 Q37689956-EDD520AE-28A1-469B-818D-F5459B49EA3D Q38060663-B1679951-D386-4AED-84F3-FF5B2E861367 Q39262264-DDCABCC9-5078-4420-BA71-2C8988AD29B2 Q41404105-A17FD599-8A89-4031-BAAF-E2DA33C2D227 Q41594948-FD3F5609-7F39-4AF0-A9B4-675CB2757610 Q42376272-3E2EF3E4-D506-419B-8BB3-DB408C986F32 Q42744052-A6933F0F-6BCB-44A5-BE18-7CC0CDD15744 Q42808096-5A37CBB1-23B5-42D3-A6B5-752A4CFA9696 Q46349050-4E12DD08-1EEB-4825-BB2A-E51414BFAE8F Q47137743-8A21C0B4-5041-4AE2-9EBA-9352DF09AE13 Q48542750-A3D2F05D-963E-4478-BC95-7B9865E44E62

P2860

Prolactin-induced mouse mammary carcinomas model estrogen resistant luminal breast cancer.

http://www.wikidata.org/entity/Q35029548

description

2011 nî lūn-bûn

@nan

2011 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Prolactin-induced mouse mammar ...... sistant luminal breast cancer.

@ast

Prolactin-induced mouse mammar ...... sistant luminal breast cancer.

@en

type

label

Prolactin-induced mouse mammar ...... sistant luminal breast cancer.

@ast

Prolactin-induced mouse mammar ...... sistant luminal breast cancer.

@en

prefLabel

Prolactin-induced mouse mammar ...... sistant luminal breast cancer.

@ast

Prolactin-induced mouse mammar ...... sistant luminal breast cancer.

@en

P1433

Q35029548-A545380E-F1C2-47A1-BF02-5CF90A0B8C2A

P1476

Q35029548-E8B74D96-57C8-4E7A-BC56-E64232820E1E

P2093

Q35029548-0B8E0B86-AD9E-4927-997C-3CF9249110E9

Q35029548-18BC9186-CA8D-45EC-B443-57424CDA9A7B

Q35029548-40059BC3-5348-4E73-B7C5-E7BB00F4BCA0

Q35029548-4F8E0BA1-CBA4-4E66-89CB-C80A6F4C6877

Q35029548-BE8F92C6-BA6C-458D-BFAF-F586CDC59C87

Q35029548-F283984D-D0DA-4896-AF77-BDE55054083F

P2860

Q35029548-02C81FF4-FB22-423C-AF85-1F98C725A221

Q35029548-141B4CBB-1F08-4774-BA01-CE3B4D0AB98E

Q35029548-1CBE1006-4A08-47BE-A4D2-C3765CBE9448

Q35029548-23B529A7-A9F4-42BD-B072-02EC068A000B

Q35029548-251186BD-12D7-4040-8973-3ABC83B261A9

Q35029548-301963A7-9AD7-4E4E-8351-1CE345224AD3

Q35029548-307DB723-9827-4FBB-88B2-E70D4F296F90

Q35029548-37BE0759-A248-437E-BA1D-A30BBD5054C7

Q35029548-380C6DD2-86D6-4D5A-8857-F27924883B0A

Q35029548-381D9B6E-825D-4432-BDD4-7B608CE9CBA4

P2888

Q35029548-E2AB11C1-BEFC-4ABA-9209-EBCE60A412E3

P304

Q35029548-2D652AEF-8648-4262-B623-36B639BE20A8

P31

Q35029548-FDA563D1-91EF-43CD-B181-17CD8E8297C3

P356

Q35029548-7682E9FB-A017-4068-9DF3-AE4111CEFFFF

P433

Q35029548-CE15E302-BD80-4602-A59E-6AF959608441

P478

Q35029548-3DAE71E9-9E21-44B8-B17E-8F29CB24FF7F

P577

Q35029548-14BEC32E-A50E-4F79-9CE4-8432EC5EEE60

P5875

Q35029548-05596FAE-A1DE-44C2-8D57-CA178D4812C9

P6179

Q35029548-DEE17A6B-7489-437B-B1A3-444158337BCB

P698

Q35029548-CF10EC20-7EB3-4110-8CE7-55A6EEE234E4

P932

Q35029548-062DC377-7025-4689-9500-F6929B7C3904

P356

P1433

Breast Cancer Research

P1476

Prolactin-induced mouse mammar ...... sistant luminal breast cancer.

@en

P2093

Debra E Rugowski

http://www.w3.org/2001/XMLSchema#string

Hallgeir Rui

http://www.w3.org/2001/XMLSchema#string

Linda A Schuler

http://www.w3.org/2001/XMLSchema#string

Lisa M Arendt

http://www.w3.org/2001/XMLSchema#string

Maria Jose Garcia-Barchino

http://www.w3.org/2001/XMLSchema#string

Tara A Grafwallner-Huseth

http://www.w3.org/2001/XMLSchema#string

P2860

FOXA1 is an essential determinant of ERalpha expression and mammary ductal morphogenesis

GATA-3 and the regulation of the mammary luminal cell fate

Multiple kinase cascades mediate prolactin signals to activating protein-1 in breast cancer cells

Gene expression profiling predicts clinical outcome of breast cancer

A gene-expression signature as a predictor of survival in breast cancer

Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1

Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease.

Development of mammary luminal progenitor cells is controlled by the transcription factor STAT5A

Janus kinase 2 is required for the initiation but not maintenance of prolactin-induced mammary cancer

Socs2 and elf5 mediate prolactin-induced mammary gland development

P2888

P304

R11

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/BCR2819

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P577

2011-01-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49793617

http://www.w3.org/2001/XMLSchema#string

P6179

1043481996

http://www.w3.org/2001/XMLSchema#string

P698

21276249

http://www.w3.org/2001/XMLSchema#string

P932

3109579

http://www.w3.org/2001/XMLSchema#string